The development of broad-spectrum antiviral drugs particulary in the context of emerging zoonotic infections for which specific interventions do not exist sheahnan et al. tested the potential of a ribonucleoside analog which was previously shown to be active against RNA viruses such as influenza and Ebola virus, to inhibit coronaviruses…
